Torrent Pharma reports 52 percent increase in profit after tax to Rs 443 crore for Q3
Torrent Pharmaceuticals has reported a 52 percent increase in its consolidated profit after tax to Rs 443 crore for the third quarter ended December 2023.The drug firm had reported a net profit of Rs 292 crore in the October-December period of the last fiscal.Its revenue increased by 10 per cent to Rs 2,732 crore in the third quarter compared to Rs 2,491 crore in the year-ago period,...
Torrent Pharmaceuticals has reported a 52 percent increase in its consolidated profit after tax to Rs 443 crore for the third quarter ended December 2023.
Read also: Torrent Pharma Gets CDSCO Panel Nod To study antidiabetic FDC Empagliflozin plus Sitagliptin
Torrent Pharma is an Indian multinational pharmaceutical company headquartered in Ahmedabad, India. The company specializes in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).
Read also: Torrent Pharma gets CDSCO Panel nod to study Brexpiprazole tablet to treat schizophrenia
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd